Scarica l'app Stockscreener
0.5866
2.33%
-0.014
Dopo l'orario di chiusura:
.59
0.0034
+0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.6006
Aprire:
$0.6018
Volume 24 ore:
329.30K
Relative Volume:
0.34
Capitalizzazione di mercato:
$23.24M
Reddito:
$1.04M
Utile/perdita netta:
$-67.50M
Rapporto P/E:
-0.3052
EPS:
-1.9222
Flusso di cassa netto:
$-60.67M
1 W Prestazione:
-3.01%
1M Prestazione:
-1.63%
6M Prestazione:
-83.71%
1 anno Prestazione:
-75.46%
Intervallo 1D:
$0.5851
$0.6073
Intervallo di 1 settimana:
$0.54
$0.6255
Portata 52W:
$0.43
$5.14
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
Nome
Vistagen Therapeutics Inc
Settore
Industria
Telefono
650-577-3600
Indirizzo
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Compare VTGN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
0.5866 | 23.24M | 1.04M | -67.50M | -60.67M | -1.9222 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-17 | Downgrade | Jefferies | Buy → Hold |
| 2025-12-17 | Downgrade | Maxim Group | Buy → Hold |
| 2025-12-17 | Downgrade | Stifel | Buy → Hold |
| 2025-12-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-07 | Aggiornamento | Maxim Group | Hold → Buy |
| 2022-07-22 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | Iniziato | Robert W. Baird | Outperform |
| 2021-02-18 | Iniziato | Jefferies | Buy |
| 2021-01-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | Iniziato | Maxim Group | Buy |
| 2018-02-08 | Reiterato | Chardan Capital Markets | Buy |
| 2017-03-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
VistaGen Faces Nasdaq Audit Committee Compliance Setback - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Vistagen Therapeutics, Inc. (VTGN) And Encourages Investors to Connect - accessnewswire.com
Vistagen Therapeutics notifies Nasdaq of audit committee non-compliance - Investing.com
Vistagen Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
[8-K] Vistagen Therapeutics, Inc. Reports Material Event - Stock Titan
Risk Report: Will Vistagen Therapeutics Inc outperform during market ralliesPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Vistagen Therapeutics, Inc. (VTGN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Encourages Vistagen Therapeutics, Inc. (VTGN) Stockholders to Inquire about Securities Investigation | NDAQ:VTGN | Press Release - Stockhouse
Pullback Watch: What is the next catalyst for Vistagen Therapeutics IncShort Setup & Weekly Top Performers Watchlists - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Vistagen Therapeutics Inc Stock Operating Data - GuruFocus
Geopolitics Watch: Will Vistagen Therapeutics Inc. outperform during market rallies2026 Opening Moves & Community Verified Trade Alerts - baoquankhu1.vn
Biopharma's Brass Hid Anxiety Drug Trial Risks, Investor Says - Law360
Vistagen Therapeutics Inc Stock Baskets - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Investors to Reach Out - ACCESS Newswire
Vistagen Therapeutics (MEX:VTGN) Dividends Paid - GuruFocus
Layoff Tracker: Takeda Restructuring Will Affect Workforce, Could Include Layoffs - biospace.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Vistagen Therapeutics, Inc. (VTGN) And Encourages Stockholders to Connect - accessnewswire.com
If You Invested $1,000 in Vistagen Therapeutics Inc (VTGN) - Stock Titan
Momentum Shift: What is the implied volatility of Vistagen Therapeutics Inc2026 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Vistagen Therapeutics, Inc. (VTGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Vistagen Therapeutics, Inc. Announces Resignation of Mary Rotunno as Director, Effective April 1, 2026 - marketscreener.com
Vistagen (NASDAQ: VTGN) director Mary Rotunno resigns from board effective April 1, 2026 - Stock Titan
VistaGen Showcases Intranasal Pherine Pipeline in New Presentation - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTGN - ChartMill
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTGN - FinancialContent
VistaGen at Stifel CNS Forum: Strategic Insights on Fasedienol By Investing.com - Investing.com Canada
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN)March 16, 2026 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Vistagen (NASDAQ: VTGN) details pherine CNS pipeline in new presentation - Stock Titan
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, - GuruFocus
Bronstein, Gewirtz & Grossman LLC Urges Vistagen - GlobeNewswire
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline Tonight - The Daily Tribune News
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, I - GuruFocus
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial - MSN
VTGN DEADLINEFINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Vistagen Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. ... - Black Hills Pioneer
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - GlobeNewswire Inc.
VTGN UPCOMING DEADLINE ON MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit (2026-03-14) - Seeking Alpha
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen LawsuitVTGN - PR Newswire
VTGN DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Vistagen Therapeutics, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
VTGN SEC FilingsVistagen Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
VTGN DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors ... - Bluefield Daily Telegraph
VTGN DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages - GlobeNewswire
VTGN Shareholder Alert: Vistagen Therapeutics, Inc. - GlobeNewswire
2026-03-13 | VTGN DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Vistagen Therapeutics, Inc. Investors to Join the Class Action Lawsuit Today | NDAQ:VTGN | Press Release - Stockhouse
Evotec, Vistagen lay off staff; Immutep shares collapse on study failure - Yahoo Finance
Vistagen Therapeutics Inc Azioni (VTGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):